Factors Associated with Postpartum Use of Long-Acting Reversible Contraception

Pregnancy and ChildbirthReproductive Health

Long-Acting Reversible Contraception for Adolescents: A Review

JAMA Pediatr.

Francis JKR, Gold MA

doi: 10.1001/

Further Publications Gynecology

Feasibility and Acceptability of a Toolkit-Based Process to Implement Patient-Centered, Immediate Postpartum Long-Acting Reversible Contraception Services

Am J Obstet Gynecol

Moniz MH, Dalton VK, Smith RD, Owens LE, Landis-Lewis Z, Peahl AF, Van Kainen B, Punch MR, Wetmore MK, Bonawitz K, Kolenic GE, Dehlendorf C, Heisler M

doi: 10.1016/j.ajog.2021.10.009

Reproductive Health

Long-acting reversible contraception immediately after medical abortion: systematic review with meta-analyses

Hum Reprod Update.

Schmidt-Hansen M, Hawkins JE, Lord J, Williams K, Lohr PA, Hasler E, Cameron S

doi: 10.1093/humupd/dmz040.

Erectile and Sexual Functions and DysfunctionsHPV and Gynecologic Cancer

Sexual Inactivity During the Last 4 Weeks in Long-Term Cervical Cancer Survivors: Prevalence and Associated Factors

J Sex Med.

Dahl AA, Bentzen AG, Fosså SD, Hess SL, Steen R, Vistad I, Kiserud CE

doi: 10.1016/j.jsxm.2020.03.010.

Pregnancy and Childbirth

Modifiable risk factors of maternal postpartum weight retention: an analysis of their combined impact and potential opportunities for prevention

Int J Obes (Lond).

Hollis JL, Crozier SR, Inskip HM, Cooper C, Godfrey KM, Harvey NC, Collins CE, Robinson SM

doi: 10.1038/ijo.2017.78.

Reproductive Health

An in-depth analysis of the use of shared decision making in contraceptive counseling

Contraception.

Chen M, Lindley A, Kimport K, Dehlendorf C

doi: 10.1016/j.contraception.

Pregnancy and ChildbirthReproductive Health

Contraceptive use by disability status: new national estimates from the National Survey of Family Growth

Contraception.

Mosher W, Hughes RB, Bloom T, Horton L, Mojtabai R, Alhusen JL

doi: 10.1016/

Pregnancy and Childbirth

Etonogestrel implant use in women primarily choosing a combined oral contraceptive pill: A proof-of-concept trial

Contraception.

Chen MJ, Hsia JK, Creinin MD

doi: 10.1016/

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract SymptomsOveractive Bladder

Nerve growth factor levels are associated with overactive bladder symptoms and long-term treatment outcome after transurethral resection of the prostate in patients with benign prostate hyperplasia

J Urol.

Hu H, Zhang W, Liu X, Wang H, Fang Z, Liang C, Wang T, Xu K

doi: 10.1016/j.juro.2018.03.130.

Related content

Long-Acting Reversible Contraception for Adolescents: A Review

Feasibility and Acceptability of a Toolkit-Based Process to Implement Patient-Centered, Immediate Postpartum Long-Acting Reversible Contraception Services

Long-acting reversible contraception immediately after medical abortion: systematic review with meta-analyses

Sexual Inactivity During the Last 4 Weeks in Long-Term Cervical Cancer Survivors: Prevalence and Associated Factors

Modifiable risk factors of maternal postpartum weight retention: an analysis of their combined impact and potential opportunities for prevention

An in-depth analysis of the use of shared decision making in contraceptive counseling

Contraceptive use by disability status: new national estimates from the National Survey of Family Growth

Etonogestrel implant use in women primarily choosing a combined oral contraceptive pill: A proof-of-concept trial

Nerve growth factor levels are associated with overactive bladder symptoms and long-term treatment outcome after transurethral resection of the prostate in patients with benign prostate hyperplasia